How Were the Elderly RA Patients Doing Over the Past Year?—A Post Hoc Analysis for Telephone Based Following Up to RA Patients in Zunyi China
Yong Chen,Yan-Juan Chen,Jian-Feng Luo,Mang He,Si-Jin Zhao,Shi-Dan Tian,Yong-Qiao Zhang,Xiao-Long Chen,Chuan-Jie Yang,Yu-Zhuo Luo,Kutty Nandakumar,Mei Tian
DOI: https://doi.org/10.2147/jir.s493145
IF: 4.5
2024-11-27
Journal of Inflammation Research
Abstract:Yong Chen, 1 Yan-Juan Chen, 1 Jian-Feng Luo, 2 Mang He, 1 Si-Jin Zhao, 3 Shi-Dan Tian, 1 Yong-Qiao Zhang, 3 Xiao-Long Chen, 3 Chuan-Jie Yang, 3 Yu-Zhuo Luo, 3 Kutty Selva Nandakumar, 4 Mei Tian 1 1 Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, Zunyi, People's Republic of China; 2 Department of Biostatistics, School of Public Health, Fudan University, Shanghai, People's Republic of China; 3 The First School of Clinical Medicine, Zunyi Medical University, Zunyi, People's Republic of China; 4 Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, Sweden Correspondence: Mei Tian, Department of Rheumatology and Immunology, Affiliated Hospital of Zunyi Medical University, 149 Dalian Road, Huichuan District, Zunyi City, Guizhou Province, 563000, People's Republic of China, Email Kutty Selva Nandakumar, Department of Medical Biochemistry and Biophysics, Karolinska Institute, Stockholm, 17177, Sweden, Email Purpose: The quality of life (QoL) of elderly patients with rheumatoid arthritis (RA) in Zunyi China based on health parameters has not been previously analyzed. This study compares the 36-Item Short Form Health Survey (SF-36) scores and prevailing health complications between < 60y and ≥ 60y patients with RA. Data from 1166 patients with RA who visited the rheumatology department of Zunyi Medical University Hospital were followed up and retrospectively analyzed. Patients and Methods: Data from 1166 patients with RA who visited the rheumatology department of Zunyi Medical University Hospital (2021.1– 2022.8) were followed up and retrospectively analyzed. Results: Twenty cases passed away at 61.55 ± 8.11y, which was 6.75 years less than the local average age of death. Elderly patients with RA reported lower recovery levels, and their levels of inflammatory markers such as Immunoglobulin M-rheumatoid factor (IgM-RF), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels were significantly higher than those of younger patients during their past one-year observation period. The SF-36 results indicated that eight items of QoL in the elderly patients were all significantly inferior to < 60y patients, while the complications of interstitial lung disease (ILD), latent tuberculosis infection (LTBI) and, lung and herpes zoster infections were significantly higher. Conclusion: Elderly patients had a higher disease activity along with poor QoL, more health-related complications, and susceptibility to infections. Our study emphasizes the imperative need for optimization of RA treatment modalities in the elderly to alleviate their sufferings. Keywords: elderly rheumatoid arthritis, SF-36 scores, clinical characteristics, treatment outcomes The elderly rheumatoid arthritis (RA) population consists of both elderly-onset RA (EORA) that manifests after the age of 60 years and individuals diagnosed with RA early in life who aged naturally to become members of this group. 1 Much attention has been paid to the EORA cohort, which is believed to possess more remarkable features of acute onset and higher disease activity. 2 Irrespective of the subtypes, elderly RA is a diagnosis criteria that combines RA and aging. Although it may seem strange to many doctors, aging is now considered as a disease that could be diagnosed according to the World Health Organization's International Classification of Diseases (ICD-10/11). 3 The elderly RA population is expanding due to increased life expectancy and EORA incidence. The autoimmune reactions due to RA foster the process of aging, known as inflammaging; 4 on the other hand, during aging, organisms tend to develop a characteristic inflammatory state that expresses higher levels of pro-inflammatory markers, leading to the patients having more susceptibility to infections, age-related disease onset, and neoplasms. 5 Adding basic principles and characteristic features of geriatrics in their diagnosis may help rheumatologists evaluate the disease development in elderly RA for designing proper treatment strategies. Direct observation of the differences in patients' age is essential; however, only a small number of research studies were undertaken along these lines. 1 As robust treatment-to-target approaches must be balanced against adverse events due to increased comorbidities observed in the elderly RA population, while the clinical characteristics are not fully validated, the management of disease development in these patients can be challenging. There is also a limitation in the treatment approac -Abstract Truncated-
immunology